Stephens Consulting’s Evolus EOLS Stock Holding History

Stephens Consulting’s Portfolio EOLS Stock Details EOLS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	$1.93K	Hold	290	–	–	﹤0.01%	353
2025 Q3	$1.78K	Hold	290	–	–	﹤0.01%	331
2025 Q2	$2.67K	Sell	290 -30	-9%	-$307	﹤0.01%	467
2025 Q1	$3.85K	Buy	320 +30	+10%	+$392	﹤0.01%	396
2024 Q4	$3.2K	Hold	290	–	–	﹤0.01%	441
2024 Q3	$4.7K	Hold	290	–	–	﹤0.01%	402
2024 Q2	$3.15K	Hold	290	–	–	﹤0.01%	464
2024 Q1	$4.06K	Hold	290	–	–	﹤0.01%	383
2023 Q4	$3.05K	Hold	290	–	–	﹤0.01%	409
2023 Q3	$2.65K	Hold	290	–	–	﹤0.01%	421
2023 Q2	$2.11K	Hold	290	–	–	﹤0.01%	437
2023 Q1	$2.45K	Hold	290	–	–	﹤0.01%	446
2022 Q4	$2.18K	Hold	290	–	–	﹤0.01%	427
2022 Q3	$2.33K	Hold	290	–	–	﹤0.01%	478
2022 Q2	$3.36K	Hold	290	–	–	﹤0.01%	443
2022 Q1	$3.25K	Hold	290	–	–	﹤0.01%	476
2021 Q4	$1.89K	Buy	+290	New	+$1.99K	﹤0.01%	621

Other funds holding EOLS

NCM

Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return

FLSM

Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

SCM

Stonepine Capital Management Bend, Oregon $250M AUM 77.6% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Stephens Consulting's EOLS Position: Q4 2025 in Review

Stephens Consulting held its Evolus (EOLS) position steady in Q4 2025 at 290 shares worth $1.93K. The position accounts for ﹤0.01% of the portfolio, ranked #353.

Stephens Consulting first reported a position in EOLS in Q4 2021 and has held it in 17 quarters since. The position peaked at $4.7K in Q3 2024. 169 funds tracked by Wall St. Rank hold EOLS as of Q4 2025.

Stephens Consulting held 290 shares of Evolus worth $1.93K as of Q4 2025.
Stephens Consulting left its Evolus share count unchanged in Q4 2025.
Evolus made up ﹤0.01% of Stephens Consulting's portfolio in Q4 2025, its #353 holding.
Stephens Consulting first reported a position in Evolus in Q4 2021 and has held it in 17 quarters since.
Stephens Consulting's Evolus position peaked at $4.7K in Q3 2024.
169 funds tracked by Wall St. Rank held Evolus as of Q4 2025.

Based on Stephens Consulting's 13F filing for Q4 2025, filed 13 Jan 2026.